Pieris Pharmaceuticals, Inc.
NASDAQ:PIRS
16.9825 (USD) • At close November 4, 2024
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | ||||||||||||
| Nettowinst
| -24.543 | -33.277 | -45.738 | -37.23 | -25.469 | -26.754 | -17.647 | -22.799 | -14.059 | -9.85 | 0.066 | -2.321 |
| Afschrijvingen & Amortisatie
| 1.904 | 2.78 | 2.368 | 2.127 | 1.04 | 0.57 | 0.369 | 0.361 | 0.308 | 0.367 | 0.385 | 0.378 |
| Uitgestelde Inkomstenbelasting
| -4.518 | 0 | 0 | 0.164 | -1.222 | -0.164 | 0.156 | -1.856 | 0 | 0.664 | 0 | 0 |
| Aandelen Gebaseerde Vergoedingen
| 3.349 | 4.402 | 5.215 | 5.09 | 5.374 | 4.943 | 3.046 | 1.905 | 1.165 | 0.571 | 0 | 0 |
| Verandering in Werkkapitaal
| -7.385 | -33.37 | 30.525 | -16.377 | -32.121 | 21.893 | 63.537 | 6.095 | -0.791 | 0.593 | -3.942 | -0.123 |
| Vorderingen
| 5.307 | -2.624 | -1.813 | 5.343 | -4.055 | 12.511 | -14.469 | -0.059 | 0 | 0.465 | -0.337 | -0.123 |
| Voorraden
| 0 | 0 | 5.734 | -2.87 | -0.799 | 0 | 3.96 | 1.041 | 0 | -1.059 | -3.169 | 0 |
| Crediteuren
| -0.789 | -4.208 | 7.049 | -4.354 | 1.257 | 0.764 | -0.332 | 1.36 | -0.091 | 1.116 | -0.549 | 0 |
| Overig Werkkapitaal
| -12.692 | -26.538 | 19.555 | -14.496 | -28.524 | 8.618 | 74.378 | 3.752 | -0.7 | 0.07 | 0.114 | 0 |
| Overige Niet-Contante Posten
| -27.144 | -0.467 | -0.03 | 0.33 | -0.069 | -1.554 | 0.293 | 1.905 | 0.671 | 2.589 | 0.414 | -7.145 |
| Kasstroom uit Operationele Activiteiten
| -53.819 | -59.932 | -7.66 | -45.896 | -52.467 | -1.066 | 49.754 | -14.388 | -12.705 | -5.066 | -3.076 | -9.087 |
| Investeringsactiviteiten: | ||||||||||||
| Investeringen in Materiële Vaste Activa
| -0.171 | -1.041 | -0.949 | -2.726 | -2.462 | -1.698 | -1.95 | -0.581 | -0.621 | -0.267 | -0.049 | -0.133 |
| Netto Overnames
| -12.173 | 20.195 | 0 | -41.938 | -12.3 | 0 | 0 | 0.021 | 0 | 0 | 0 | 0 |
| Aankoop van Beleggingen
| -22.835 | -48.395 | 0 | -41.499 | -59.317 | -117.582 | -43.925 | 0 | 0 | 0 | 0 | 0 |
| Verkoop/verval van Beleggingen
| 35.008 | 28.2 | 0 | 83.437 | 71.617 | 110.405 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overige Investeringsactiviteiten
| 12.173 | -20.195 | 0 | 41.938 | 12.3 | -7.177 | -43.925 | 0.021 | 0 | 0 | 0 | 0 |
| Kasstroom uit Investeringsactiviteiten
| 12.002 | -21.236 | -0.949 | 39.212 | 9.838 | -8.875 | -45.875 | -0.56 | -0.621 | -0.267 | -0.049 | -0.133 |
| Financieringsactiviteiten: | ||||||||||||
| Schuldaflossingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.158 | -0.182 | -0.327 | 0 |
| Uitgifte van Gewone Aandelen
| 19.795 | 7.214 | 57.101 | 9.624 | 30.998 | 47.211 | 4.09 | 15.221 | 25.764 | 11.963 | 0 | 0 |
| Terugkoop van Gewone Aandelen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgekeerde Dividenden
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overige Financieringsactiviteiten
| 19.795 | 7.214 | 2.026 | 0.491 | 1.168 | 1.3 | 4.09 | 15.221 | 0.01 | 8.552 | 0.327 | 2.317 |
| Kasstroom uit Financieringsactiviteiten
| 19.795 | 7.214 | 59.127 | 10.115 | 32.166 | 48.511 | 4.09 | 15.221 | 24.616 | 20.334 | 0.327 | 2.317 |
| Overige Informatie: | ||||||||||||
| Effect van Wisselkoersveranderingen op Kas
| 0.783 | -5.175 | -3.19 | 4.745 | -2.144 | -1.581 | 0.553 | -0.267 | -0.415 | -0.216 | 0.161 | 0.017 |
| Netto Kasstroomverandering
| -21.239 | -79.129 | 47.328 | 8.176 | -12.607 | 36.989 | 8.522 | 0.006 | 10.875 | 14.785 | -2.638 | -6.886 |
| Kaspositie aan het Einde van de Periode
| 17.396 | 38.635 | 117.764 | 70.436 | 62.26 | 74.867 | 37.878 | 29.356 | 29.349 | 18.474 | 3.689 | 6.327 |